Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomasz Burzykowski

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
Annals of Translational Medicine|July 20, 2018
The search for surrogate endpoints for immunotherapy trialsMarc Buyse, Tomasz Burzykowski, Everardo D Saad
JAMA Oncology|November 29, 2016
Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionTomasz Burzykowski, Everardo D Saad, Marc Buyse
European Journal of Cancer (Oxford, England : 1990)|May 30, 2006
Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trialsLaurence Collette, Tomasz Burzykowski, Fritz H Schröder
Statistics in Medicine|September 22, 2015
Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference testLeandro García Barrado, Els Coart, Tomasz Burzykowski, et al.
Journal of Surgical Oncology|October 2, 2002
Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?Gábor Cserni, Vincent Vinh-Hung, Tomasz Burzykowski
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|January 23, 2015
A nonhomogeneous hidden markov model for gene mapping based on next-generation sequencing dataFatemeh Zamanzad Ghavidel, Jürgen Claesen, Tomasz Burzykowski
Biometrics|September 7, 2016
Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-testLeandro García Barrado, Els Coart, Tomasz Burzykowski
The New England Journal of Medicine|November 1, 2016
Adaptive Randomization of Neratinib in Early Breast CancerMarc Buyse, Everardo D Saad, Tomasz Burzykowski
Journal of the American Society for Mass Spectrometry|February 22, 2012
An efficient method to calculate the aggregated isotopic distribution and exact center-massesJürgen Claesen, Piotr Dittwald, Tomasz Burzykowski, et al.
Journal for Immunotherapy of Cancer|November 30, 2018
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated resultsJacek Mackiewicz, Tomasz Burzykowski, Dariusz Iżycki, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
Annals of Translational Medicine|July 20, 2018
The search for surrogate endpoints for immunotherapy trialsMarc Buyse, Tomasz Burzykowski, Everardo D Saad
JAMA Oncology|November 29, 2016
Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionTomasz Burzykowski, Everardo D Saad, Marc Buyse
European Journal of Cancer (Oxford, England : 1990)|May 30, 2006
Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trialsLaurence Collette, Tomasz Burzykowski, Fritz H Schröder
Statistics in Medicine|September 22, 2015
Development of a diagnostic test based on multiple continuous biomarkers with an imperfect reference testLeandro García Barrado, Els Coart, Tomasz Burzykowski, et al.
Journal of Surgical Oncology|October 2, 2002
Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas?Gábor Cserni, Vincent Vinh-Hung, Tomasz Burzykowski
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology|January 23, 2015
A nonhomogeneous hidden markov model for gene mapping based on next-generation sequencing dataFatemeh Zamanzad Ghavidel, Jürgen Claesen, Tomasz Burzykowski
Biometrics|September 7, 2016
Estimation of diagnostic accuracy of a combination of continuous biomarkers allowing for conditional dependence between the biomarkers and the imperfect reference-testLeandro García Barrado, Els Coart, Tomasz Burzykowski
The New England Journal of Medicine|November 1, 2016
Adaptive Randomization of Neratinib in Early Breast CancerMarc Buyse, Everardo D Saad, Tomasz Burzykowski
Journal of the American Society for Mass Spectrometry|February 22, 2012
An efficient method to calculate the aggregated isotopic distribution and exact center-massesJürgen Claesen, Piotr Dittwald, Tomasz Burzykowski, et al.
Journal for Immunotherapy of Cancer|November 30, 2018
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated resultsJacek Mackiewicz, Tomasz Burzykowski, Dariusz Iżycki, et al.
Pageof 15